CoChat

Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas

Open access

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

We carried out a population-based study on low-grade diffuse gliomas in the Canton of Zurich, Switzerland (population 1.16 million). From 1980 to 1994, 987 astrocytic and oligodendroglial tumors were diagnosed, of which 122 (12.4%) were low-grade (WHO grade II). The incidence rates adjusted to the World Standard Population, per million population per year, were 2.28 for low-grade diffuse astrocytomas, 0.89 for oligoastrocytomas, and 2.45 for oligodendrogliomas. The survival rate (mean follow-up 7.5+/-4.8 years) was highest for patients with oligodendroglioma (78% at 5 years, 51% at 10 years), followed by those with oligoastrocytoma (70% at 5 years, 49% at 10 years) and fibrillary astrocytoma (65% at 5 years, 31% at 10 years). Survival of patients with gemistocytic astrocytoma was poor, with survival rates of 16% at 5 years and 0% at 10 years. Younger patients (<50 years) survived significantly longer than older patients (>50 years; P=0.013). DNA sequencing, performed in 84% of cases, revealed that TP53 mutations were most frequent in gemistocytic astrocytomas (88%), followed by fibrillary astrocytomas (53%) and oligoastrocytomas (44%), but were infrequent (13%) in oligodendrogliomas. The presence of TP53 mutations was associated with shorter survival of patients with low-grade diffuse gliomas (log-rank test; P=0.047), but when each histological type was analyzed separately, an association was observed only for oligoastrocytoma ( P=0.05). Loss on 1p and 19q were assessed by quantitative microsatellite analysis in 67% of cases. These alterations were frequent in oligodendrogliomas (1p, 57%; 19q, 69%), less common in oligoastrocytomas (1p, 27%; 19q, 45%), rare in fibrillary astrocytomas (1p, 7%; 19q, 7%), and absent in gemistocytic astrocytomas. None of these alterations were predictive of survival. These results establish the frequency of key genetic alterations in low-grade diffuse gliomas at a population-based level. Multivariate Cox's regression analysis indicates that only age and histological type, but not genetic alterations, are significant predictive factors.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00401-004-0861-z

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Cited by

See all 330

Metadata

Authors
Okamoto, Y., Di Patre, P.-L., Burkhard, C., Horstmann, S., Jourde, B., Fahey, M., Schüler, D., Probst-Hensch, N. M., Yasargil, M. G., Yonekawa, Y., Lütolf, U. M., Kleihues, P., & Ohgaki, H.
Affiliations
  • Centre international de recherche sur le cancer (FR)
  • Kanton Zürich (CH)
  • University Hospital Zurich (CH)
Corresponding author
Ohgaki, Hiroko
Venue
Acta Neuropathologica
Published
2004-04-28
Volume
108
Issue
1
Pages
49-56
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2059995145
Cited by
330
References
32
Citations by year
2026: 2 · 2025: 6 · 2024: 4 · 2023: 16 · 2022: 16 · 2021: 10 · 2020: 7 · 2019: 7 · 2018: 22 · 2017: 15 · 2016: 12 · 2015: 22 · 2014: 20 · 2013: 23 · 2012: 24
FWCI
7.35
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Acta Neuropathologica (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
  • Digital Commons - East Tennessee State University (East Tennessee State University) (submittedVersion)
  • Swinburne figshare (Swinburne University of Technology) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Foundation for Promotion of Cancer Research
Topics
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords
diffuse astrocytoma, oligodendroglioma, oligoastrocytoma, fibrillary astrocytoma, gemistocytic astrocytoma, incidence, survival, TP53 mutation, 1p/19q codeletion, loss of heterozygosity, DNA sequencing, microsatellite analysis, age and survival
MeSH terms
Age Factors, Aged, Astrocytoma, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, DNA Mutational Analysis, Exons, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mutation, Oligodendroglioma, Retrospective Studies, Sex Factors, Incidence, Survival Rate, Multivariate Analysis, Tumor Suppressor Protein p53, Neurosurgical Procedures, Loss of Heterozygosity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. https://app.cochat.ai/papers/10.1007/s00401-004-0861-z
The paper
Okamoto, Y., Di Patre, P.-L., Burkhard, C., Horstmann, S., Jourde, B., Fahey, M., Schüler, D., Probst-Hensch, N. M., Yasargil, M. G., Yonekawa, Y., Lütolf, U. M., Kleihues, P., & Ohgaki, H. (2004). Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathologica. https://doi.org/10.1007/s00401-004-0861-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.